Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
27,461
archived clinical trials in
Hematology

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2016
All Children's Hospital
2130
mi
from 91732
Saint Petersburg, FL
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2016
All Children's Hospital
2130
mi
from 91732
Saint Petersburg, FL
Click here to add this to my saved trials
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2016
Children's Healthcare of Atlanta - Egleston
1922
mi
from 91732
Atlanta, GA
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2016
Children's Healthcare of Atlanta - Egleston
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2016
Lurie Children's Hospital- Chicago
1730
mi
from 91732
Chicago, IL
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2016
Lurie Children's Hospital- Chicago
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2016
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2016
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2016
Royal Childrens Hospital
7197
mi
from 91732
Herston,
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2016
Royal Childrens Hospital
7197
mi
from 91732
Herston,
Click here to add this to my saved trials
Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia
Phase II Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia
Status: Enrolling
Updated:  3/21/2016
Dana-Farber Cancer Institute
2578
mi
from 91732
Boston, MA
Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia
Phase II Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia
Status: Enrolling
Updated: 3/21/2016
Dana-Farber Cancer Institute
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Bortezomib With Melphalan and Prednisone for Multiple Myeloma
A Prospective Study of Bortezomib in Combination With Melphalan and Prednisone for Patients With Previously Untreated Multiple Myeloma
Status: Enrolling
Updated:  3/21/2016
Duke Univ Med Ctr
2203
mi
from 91732
Durham, NC
Bortezomib With Melphalan and Prednisone for Multiple Myeloma
A Prospective Study of Bortezomib in Combination With Melphalan and Prednisone for Patients With Previously Untreated Multiple Myeloma
Status: Enrolling
Updated: 3/21/2016
Duke Univ Med Ctr
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
1786
mi
from 91732
Huntsville, AL
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
1786
mi
from 91732
Huntsville, AL
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
1753
mi
from 91732
Mobile, AL
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
1753
mi
from 91732
Mobile, AL
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
1546
mi
from 91732
Jonesboro, AR
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
1546
mi
from 91732
Jonesboro, AR
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
5
mi
from 91732
Duarte, CA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
5
mi
from 91732
Duarte, CA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative site
25
mi
from 91732
Los Angeles, CA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative site
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
358
mi
from 91732
San Francisco, CA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
358
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
2321
mi
from 91732
Miami, FL
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
1922
mi
from 91732
Atlanta, GA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
2132
mi
from 91732
Savannah, GA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
2132
mi
from 91732
Savannah, GA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
1616
mi
from 91732
Peoria, IL
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
1616
mi
from 91732
Peoria, IL
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
1655
mi
from 91732
New Orleans, LA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
1655
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative site
2578
mi
from 91732
Boston, MA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative site
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
1965
mi
from 91732
Detroit, MI
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
1965
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
1504
mi
from 91732
Brunsville, MN
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
1504
mi
from 91732
Brunsville, MN
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigator Site
653
mi
from 91732
Albuquerque, NM
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigator Site
653
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis
2435
mi
from 91732
New York, NY
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
2031
mi
from 91732
Cleveland, OH
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
2031
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis
829
mi
from 91732
Portland, OR
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis
829
mi
from 91732
Portland, OR
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
924
mi
from 91732
Lubbock, TX
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
924
mi
from 91732
Lubbock, TX
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
2277
mi
from 91732
Arlington, VA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
2277
mi
from 91732
Arlington, VA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
965
mi
from 91732
Seattle, WA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
965
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
939
mi
from 91732
Tacoma, WA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
939
mi
from 91732
Tacoma, WA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
833
mi
from 91732
Vancouver, WA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
833
mi
from 91732
Vancouver, WA
Click here to add this to my saved trials
Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)
Phase II Trial Evaluating the Safety and Efficacy of Rituximab as Primary Treatment for Extensive Chronic Graft Versus Host Disease
Status: Enrolling
Updated:  3/22/2016
Northside Hospital
1918
mi
from 91732
Atlanta, GA
Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)
Phase II Trial Evaluating the Safety and Efficacy of Rituximab as Primary Treatment for Extensive Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 3/22/2016
Northside Hospital
1918
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia
A Pilot Study to Evaluate the Safety and Preliminary Evidence of a Therapeutic Effect of ODSH (2-0, 3-0, Desulfated Heparin) in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia
Status: Enrolling
Updated:  3/22/2016
Huntsman Cancer Institute
572
mi
from 91732
Salt Lake City, UT
Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia
A Pilot Study to Evaluate the Safety and Preliminary Evidence of a Therapeutic Effect of ODSH (2-0, 3-0, Desulfated Heparin) in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia
Status: Enrolling
Updated: 3/22/2016
Huntsman Cancer Institute
572
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Genesis Cancer Center
1419
mi
from 91732
Hot Springs, AR
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Genesis Cancer Center
1419
mi
from 91732
Hot Springs, AR
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
UCLA
25
mi
from 91732
Los Angeles, CA
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
UCLA
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
St. Joseph Heritage Healthcare
402
mi
from 91732
Santa Rosa, CA
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
St. Joseph Heritage Healthcare
402
mi
from 91732
Santa Rosa, CA
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Florida Cancer Specialists
2203
mi
from 91732
Fort Myers, FL
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Florida Cancer Specialists
2203
mi
from 91732
Fort Myers, FL
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
1730
mi
from 91732
Chicago, IL
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Crescent City Research Consortium, LLC
1655
mi
from 91732
Marrero, LA
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Crescent City Research Consortium, LLC
1655
mi
from 91732
Marrero, LA
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Massachusetts General Hospital
2578
mi
from 91732
Boston, MA
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Massachusetts General Hospital
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Forrest General Cancer Center
1675
mi
from 91732
Hattiesburg, MS
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Forrest General Cancer Center
1675
mi
from 91732
Hattiesburg, MS
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Nebraska Cancer Specialists
1295
mi
from 91732
Omaha, NE
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Nebraska Cancer Specialists
1295
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Memorial Sloan-Kettering
2432
mi
from 91732
New York, NY
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Memorial Sloan-Kettering
2432
mi
from 91732
New York, NY
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Levine Cancer Institute
2102
mi
from 91732
Charlotte, NC
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Levine Cancer Institute
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Oncology and Hematology Care Inc - Blue Ash
1887
mi
from 91732
Cincinnati, OH
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Oncology and Hematology Care Inc - Blue Ash
1887
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Cleveland Clinic
2035
mi
from 91732
Cleveland, OH
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Cleveland Clinic
2035
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Ohio State University
1959
mi
from 91732
Columbus, OH
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Ohio State University
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Prairie Lakes Health Care System
1336
mi
from 91732
Watertown, SD
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Prairie Lakes Health Care System
1336
mi
from 91732
Watertown, SD
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Sarah Cannon Research Institute
1762
mi
from 91732
Nashville, TN
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Sarah Cannon Research Institute
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Simmons Cancer Center - UT Southwestern Medical Center
1223
mi
from 91732
Dallas, TX
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Simmons Cancer Center - UT Southwestern Medical Center
1223
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Virginia Cancer Specialists, PC
2269
mi
from 91732
Fairfax, VA
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Virginia Cancer Specialists, PC
2269
mi
from 91732
Fairfax, VA
Click here to add this to my saved trials